Operating profit before deduction of amortization: Adaptive Biotechnologies Corporation (ADPT)
By assembling a staff of leading geneticists and immunologists, Adaptive Biotechnologies (ADPT) has established a foundation for a breakthrough. The operating profit (EBIT) trend on the GURU.Markets chart has reached a peak, where the value 0.00 represents the current figure. This confirms its status as a leader in precision diagnostics with AI-driven system mapping, while an active R&D pipeline guarantees the release of innovations in targeted oncology.
Adaptive Biotechnologies Corporation (ADPT) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Adaptive Biotechnologies|ADPT - Long-Term Debt to Capital|Current Liabilities to Capital Adaptive Biotech|ADPT - Company Aggregate Debts|Debts to Book Capitalization Adaptive Biotechnologies|ADPT - Company Long-Term Debts|Company Short-Term Indebtedness Adaptive Biotechnologies|Quick Ratio adaptivebiotech.com
- earnings and multiples data:
ADPT - Company Net Income|Forward Earnings Adaptive Biotechnologies|ADPT - Price to Earnings Ratio|Market Cap to Future Earnings Ratio adaptivebiotech.com|ADPT - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Adaptive Biotechnologies|ADPT - Operating profit before deduction of amortization|Earnings per share for the last twelve months Adaptive Biotechnologies|ADPT - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months adaptivebiotech.com|ADPT - Net earnings per share growth this year|Expected earnings per share trend next year Adaptive Biotechnologies
Summary company analytics:ADPT (Adaptive Biotechnologies Inc.)
The integration of immune profiling platforms into long-term drug development cycles provides Adaptive Biotechnologies (ADPT) with a steady stream of revenue from genetic code analysis. This metric measures the actual cash flow from core operations, excluding paper profits, allowing investors to assess the issuer's real solvency and margin of safety through historical EBITDA_Co data.
Who Adaptive Biotechnologies competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|celldex.com - Operating profit before amortization|Operating profit EBITDA AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Profit before interest, taxes and amortization|Vera Pharma - Operating profit EBITDA|DNTH - Operating profit EBITDA|PHVS: Operating profit EBITDA|Operating profit before amortization ABCL|TRML (Tourmaline Bio) - Operating profit EBITDA|Operating profit EBITDA Precigen Inc|Profit before payment of interest, taxes and amortization Pharming (PHAR)|NKTR: Profit before deduction of interest, taxes, depreciation and amortization|Upstream Bio Inc - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization ZBIO (zenasbio.com)|Immunome - Operating profit EBITDA|Operating income before deduction of amortization Gossamer Bio Inc GOSS|KALV (KalVista Pharmaceuticals Inc) - Operating profit before deduction of amortization|SEPN (Septerna Pharma) - Profit before payment of interest, taxes and amortization|PVLA (Pieris Pharmaceuticals) - Operating profit EBITDA|Profit before interest, taxes and amortization savarapharma.com SVRA|Operating profit before deduction of amortization RIGL (Rigel Pharmaceuticals, Inc.)|ANAB (AnaptysBio Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ATXS (Astria Pharma)|enGene Corp - Profit before payment of interest, taxes and amortization|RAPT Therapeutics - Operating profit EBITDA|Operating income before deduction of amortization Aerovate Therapeutics Inc JBIO|Aclaris Therapeutics, Inc. (ACRS) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Kyverna Therapeutics Inc. (KYTX)|Operating profit before deduction of amortization TLSA|CABA (Cabaletta Bio Inc) - Company profit before taxes, interest and amortization|Operating profit EBITDA VTYX|THTX - Profit before interest, taxes and amortization|Operating profit EBITDA AVTX (Avalo Therapeutics)|ELDN - Operating profit before deduction of amortization|Agenus Inc - Operating profit EBITDA|Income before deduction of interest, taxes and amortization CLYM (Climb Bio, Inc)|Zura Bio (ZURA) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ATYR|Profit before payment of interest, taxes and amortization Adagene Inc|Profit before interest, taxes and amortization Ikena Oncology, Inc. IMA|Profit before payment of interest, taxes and amortization Shattuck Labs, Inc. (STTK)|Profit before payment of interest, taxes and amortization EQ (equilliumbio.com)|Profit before payment of interest, taxes and amortization Connect Biopharma Holdings Limited CNTB|Immunic Therapeutics (IMUX) - Profit before interest, taxes and amortization|Atara Biotherapeutics Inc - Operating profit EBITDA|Operating profit before depreciation charges InflaRx N.V. (IFRX)|XFOR: Operating profit EBITDA|ACET - Operating income before deduction of amortization|CELU (Celularity Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization inmunebio.com INMB|Profit before payment of interest, taxes and amortization Barinthus Biotherapeutics plc (BRNS)|Operating income before deduction of amortization Kezar Life Sciences Inc.|Operating profit EBITDA SABS (SAB Biotherapeutics, Inc)|Operating profit EBITDA Akari Therapeutics, Plc AKTX|Enlivex Therapeutics, Ltd. - Operating profit EBITDA|QTTB (Q32 Bio Inc.) - Operating profit before amortization|GeoVax (GOVX) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization EDSA (Edesa Biotech Inc)|Operating profit before deduction of amortization IBIO|CARM (Carisma Tx) - Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization XTL Biopharmaceuticals (XTLB)|BOLT: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA HCWB (HCW Biologics)|Income before deduction of interest, taxes and amortization APVO|AIM ImmunoTech Inc. - Operating profit EBITDA|ADTX - Operating profit EBITDA|GRI Bio, Inc. (GRI) - Profit before payment of interest, taxes and amortization|xortx.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Vyome Holdings|Operating profit before deduction of amortization Revelation Biosciences Inc (REVB)|Operating profit EBITDA INDP|Operating profit EBITDA BiondVax Pharmaceuticals (SCNI)|CalciMedica - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AFMD|Allakos Therapeutics - Operating profit EBITDA|Operating income before deduction of amortization HOOKIPA Pharma Inc. HOOK|igmbio.com (IGMS) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization iTeos Pharma|Profit before payment of interest, taxes and amortization Ocean Biomedical, Inc.|Operating profit before deduction of amortization tcbiopharm.com (TCBP)|Operating profit before deduction of amortization THRD (Third Harmonic Bio, Inc.)
